We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-4.22%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$740M
AUM Growth
+$30.5M
Cap. Flow
-$239M
Cap. Flow %
-32.31%
Top 10 Hldgs %
67%
Holding
218
New
56
Increased
59
Reduced
50
Closed
36

Top Buys

Rank Stock Value
1
BTBT icon
Bit Digital
BTBT
+$40.7M
2
SLAI
SOLAI Ltd ADS
SLAI
+$15.2M
3
VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
+$7.02M
4
FLUX icon
Flux Power
FLUX
+$6.05M
5
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$5.87M

Top Sells

Rank Stock Value
1
LNAI
Lunai Bioworks
LNAI
+$7.71M
2
ATOS icon
Atossa Therapeutics
ATOS
+$4.06M
3
ATER icon
Aterian
ATER
+$4M
4
ASXC
Asensus Surgical, Inc.
ASXC
+$2.95M
5
RDHL
Redhill Biopharma
RDHL
+$2.34M

Sector Composition

Rank Sector Weight
1 Healthcare 6.89%
2 Financials 5.45%
3 Technology 3.65%
4 Industrials 1.84%
5 Communication Services 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYRN
76
DELISTED
CYREN Ltd.
CYRN
$1.24M 0.17%
+100,000
New +$1.17M
TRIL
77
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.23M 0.17%
70,000
-73,496
-51% -$859K
ASLN
78
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$1.23M 0.17%
17,210
-1,922
-10% -$219K
LSTA icon
79
Lisata Therapeutics
LSTA
$10.6M
$1.16M 0.16%
+63,616
New +$1.25M
IMG
80
DELISTED
CIMG Inc
IMG
$1.1M 0.15%
713
-230
-24% -$437K
AMPG icon
81
AmpliTech
AMPG
$124M
$1.09M 0.15%
305,255
+76,153
+33% +$293K
AFIB
82
DELISTED
Acutus Medical Inc
AFIB
$1.06M 0.14%
119,755
+16,655
+16% +$219K
AUPH icon
83
CALL
Aurinia Pharmaceuticals
AUPH
$1.92B
$1.04M 0.14%
469
– –
XELA
84
PUT
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$983K 0.13%
+1
New +$10.2K
POL
85
DELISTED
Polished.com Inc.
POL
$948K 0.13%
6,035
+5,463
+955% +$823K
VANI icon
86
Vivani Medical
VANI
$113M
$931K 0.13%
97,324
+39,024
+67% +$439K
CBAT icon
87
PUT
CBAK Energy Technology Ltd
CBAT
$43.6M
$920K 0.12%
3,521
-7,568
-68% -$25.2K
BPTS
88
DELISTED
Biophytis SA American Depositary Share (0.01 Euro)
BPTS
$893K 0.12%
258
+30
+13% +$106K
ORMP icon
89
Oramed Pharmaceuticals
ORMP
$171M
$887K 0.12%
+40,344
New +$687K
MRTX
90
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$885K 0.12%
5,000
-1,000
-17% -$161K
ATHX
91
CALL
DELISTED
Athersys, Inc. Common Stock
ATHX
$881K 0.12%
265
+92
+53% +$3.5K
NRXP icon
92
PUT
NRX Pharmaceuticals
NRXP
$152M
$858K 0.12%
+93
New +$12.1K
STAB
93
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$847K 0.11%
366,460
-33,620
-8% -$127K
CRIS icon
94
CALL
Curis
CRIS
$9.41M
$843K 0.11%
+3
New +$9.37K
GFAIW icon
95
Guardforce AI Warrant
GFAIW
$816K 0.11%
+1,020,389
New +$842K
IKT icon
96
Inhibikase Therapeutics
IKT
$363M
$808K 0.11%
70,836
+636
+0.9% +$8.6K
NMRD
97
PUT
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$792K 0.11%
1,318
-687
-34% -$4.95K
CRIS icon
98
Curis
CRIS
$9.41M
$785K 0.11%
+251
New +$784K
LSTA icon
99
PUT
Lisata Therapeutics
LSTA
$10.6M
$776K 0.1%
424
-270
-39% -$5.29K
BIOR
100
PUT
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$772K 0.1%
+20
New +$8.58K
2 3
4
5 6

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q3 2021 Portfolio in Review

As of Q3 2021, Sabby Management held 218 positions worth $740M, up 4.3% from $709M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Sabby Management withdrew a net $239M in Q3 2021, closing 36 positions and reducing 50 holdings. Its most notable exit was Atossa Therapeutics, an estimated $4.06M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.9% of assets, down from 10% a quarter earlier, followed by Financials and Technology.

Against the trend, Sabby Management opened a new position in Bit Digital worth $30.5M.

  • Sabby Management's largest Q3 2021 buy was Bit Digital: 4,216,310 shares worth $30.5M.
  • Sabby Management added most to Virpax Pharmaceuticals, Inc. Common Stock in Q3 2021, an estimated $7.02M increase.
  • Sabby Management's biggest Q3 2021 reduction was Lunai Bioworks, cutting an estimated $7.71M.
  • Sabby Management fully exited Atossa Therapeutics in Q3 2021, selling an estimated $4.06M.
  • Sabby Management's ten largest holdings make up 67% of its $740M portfolio in Q3 2021.
  • Sabby Management opened 56 new positions and closed 36 in Q3 2021.
  • Sabby Management's portfolio value rose 4.3% quarter-over-quarter to $740M.

Based on Sabby Management's 13F filing for Q3 2021, filed 15 Nov 2021.